Focused Protein degradation is being explored as an alternative system in cancer, whereby the normal protein degradation procedure is co-opted for therapeutic purposes. Not long ago developed novel molecules termed proteolysis-focusing on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. A single ligand binds into the https://www.directivepublications.org/journal-of-clinical-breast-cancer/